{
    "ticker": "OPXS",
    "name": "OptiScan Biomedical Corporation",
    "description": "OptiScan Biomedical Corporation is a medical technology company focused on the development and commercialization of innovative medical devices and diagnostic solutions for critical care and hospital settings. Founded in 2004, OptiScan is known for its groundbreaking products that enhance patient safety and improve clinical outcomes. The company's flagship product, the OptiScanner, is an advanced continuous glucose monitoring system that provides real-time data to healthcare professionals, allowing for better management of patients with diabetes, particularly those in intensive care units (ICUs). By integrating advanced technology with user-friendly design, OptiScan aims to reduce the risks associated with glucose variability in critically ill patients. The company is committed to advancing healthcare through innovative solutions that enhance patient care and streamline clinical workflows. OptiScan's mission is to transform the standard of care in critical settings, ensuring that medical staff have the tools they need to deliver timely and effective treatment. With a focus on research and development, the company continues to explore new technologies and expand its product offerings to meet the evolving needs of healthcare providers.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Cleveland, Ohio, USA",
    "founded": "2004",
    "website": "https://www.optiscanbiomedical.com",
    "ceo": "A. Keith Huber",
    "social_media": {
        "twitter": "https://twitter.com/OptiScanBio",
        "linkedin": "https://www.linkedin.com/company/optiscan-biomedical-corporation/"
    },
    "investor_relations": "https://www.optiscanbiomedical.com/investor-relations",
    "key_executives": [
        {
            "name": "A. Keith Huber",
            "position": "CEO"
        },
        {
            "name": "Paul G. Kauffman",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Monitoring Devices",
            "products": [
                "OptiScanner"
            ]
        }
    ],
    "seo": {
        "meta_title": "OptiScan Biomedical Corporation | Innovative Medical Devices",
        "meta_description": "Explore OptiScan Biomedical Corporation, a leader in medical technology focused on critical care solutions. Learn about their innovative products and commitment to patient safety.",
        "keywords": [
            "OptiScan",
            "Medical Devices",
            "Continuous Glucose Monitoring",
            "Healthcare Innovation",
            "Patient Safety"
        ]
    },
    "faq": [
        {
            "question": "What does OptiScan Biomedical specialize in?",
            "answer": "OptiScan Biomedical specializes in developing innovative medical devices and diagnostic solutions for critical care."
        },
        {
            "question": "Who is the CEO of OptiScan Biomedical?",
            "answer": "A. Keith Huber is the CEO of OptiScan Biomedical Corporation."
        },
        {
            "question": "Where is OptiScan Biomedical headquartered?",
            "answer": "OptiScan Biomedical is headquartered in Cleveland, Ohio, USA."
        },
        {
            "question": "What is the main product of OptiScan?",
            "answer": "The main product of OptiScan is the OptiScanner, a continuous glucose monitoring system."
        },
        {
            "question": "When was OptiScan Biomedical founded?",
            "answer": "OptiScan Biomedical was founded in 2004."
        }
    ],
    "competitors": [
        "MDT",
        "BGN",
        "DXCM"
    ],
    "related_stocks": [
        "ABBV",
        "JNJ",
        "PFE",
        "BMY"
    ]
}